Marketed Drugs Hematology

HematologyDrug News

Hematology Jobs

Find an open position today!

Sciele Pharma Receives a Boost by Recently Expanded Product Lines

Sciele Pharma has already launched 10 drugs and more treatments are on their way. by Ronald Maldonado Rodriguez, PhD MSc , 10/04/2008




SelectedRegional Hematology Drug Revenues (milion USD)
EPOETIN ALFA2245.0TIBOTEC THERAPEUTICS2009, Worldwide
EPOETIN BETA1508.98ROCHE HOLDING LTD2009, Worldwide
RECOMBINANT FACTOR VIII1278.72BAYER AG2009, Worldwide
DEFERASIROX652.0NOVARTIS AG2009, Worldwide
DEFERASIROX405.0NOVARTIS AG2009, Rest Of The World
DEFERASIROX247.0NOVARTIS AG2009, U.S.
RECOMBINANT COAGULATION FACTOR IX98.0WYETH PHARMACEUTICALS2009, Worldwide
HEPARIN SODIUMJul 1, 2010SAGENT PHARMACEUTICALS INC
TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDEMay 5, 2010GLENMARK GENERICS LIMITED
HEPARIN SODIUMJul 1, 2010SAGENT PHARMACEUTICALS INC
DEFEROXAMINE MESYLATESep 15, 2009APP PHARMACEUTICALS
SULFACETAMIDE SODIUMMay 21, 2009TARO PHARMACEUTICAL INDUSTRIES LTD
CYANOCOBALAMINApr 1, 2009STRATIVA PHARMACEUTICALS